News

Prelude Therapeutics Announces Participation in Healthcare Conference

Prelude Therapeutics Announces Participation in Healthcare Conference

Prelude Therapeutics to Present at Major Healthcare Event

Prelude Therapeutics Incorporated (PRLD), a leading clinical-stage company focused on precision oncology, is set to participate in a prominent global healthcare conference. This event highlights the latest advancements in cancer treatment and research. With a focus on innovative therapies, Prelude is actively engaged in developing groundbreaking solutions for patients in urgent need.

Details of the Event

On March 11, 2025, Prelude's leadership team will engage in a fireside chat during the Barclays 27th Annual Global Healthcare Conference. Scheduled for 12:30 p.m. ET, this session will feature insights from Kris Vaddi, Ph.D., Chief Executive Officer; Jane Huang, M.D., President and Chief Medical Officer; and Bryant Lim, Chief Financial Officer. Their discussion will center around the company's advancements and future directions in precision oncology.

Webcast Availability

For individuals unable to attend the event in person, Prelude Therapeutics is providing a live webcast of the fireside chat. This can be accessed via the company’s official website under the Events and Presentations section. In addition to the live stream, a recorded version of the session will be archived for 90 days, allowing audiences to catch up on the discussions at their convenience.

Focus on Precision Medicine

Prelude Therapeutics is dedicated to revolutionizing cancer treatment through its extensive pipeline of innovative drug candidates. The company's portfolio includes several first-in-class SMARCA2 degraders and an advanced CDK9 inhibitor, all designed to meet the critical needs of cancer patients. By harnessing the power of targeted protein degradation, Prelude aims to deliver next-generation therapies that will enhance the effectiveness of cancer treatments.

Investor Relations

Prelude invites investors and interested parties to learn more about its innovative approach to oncology. For inquiries, Robert Doody, the Senior Vice President of Investor Relations, is available at 484.639.7235 or via email.

About Prelude Therapeutics

Prelude Therapeutics is at the forefront of developing targeted oncology therapies that address significant unmet medical needs. The company is committed to extending the benefits of precision medicine to all cancer patients through innovative solutions and strategic partnerships.

Frequently Asked Questions

What is the Barclays Healthcare Conference?

The Barclays Healthcare Conference is an annual event that brings together leaders in healthcare and biotechnology to discuss current innovations, trends, and challenges in the industry.

Who will represent Prelude Therapeutics at the conference?

Kris Vaddi, Ph.D., Jane Huang, M.D., and Bryant Lim are the key executives who will represent Prelude Therapeutics in the fireside chat at the conference.

How can I access the webcast of the fireside chat?

The webcast can be accessed through Prelude Therapeutics' official website in the Events and Presentations section on the day of the event.

What kind of therapies is Prelude Therapeutics developing?

Prelude is developing several innovative therapies, including SMARCA2 degraders and a CDK9 inhibitor, aimed at improving treatment outcomes for cancer patients.

How can investors contact Prelude Therapeutics?

Investors can contact Robert Doody, Senior Vice President of Investor Relations, at 484.639.7235 for any inquiries related to the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nakama's AniBiz Gains Power with New Investments

Updated Category News Views 43

Anime Titans Back AniBiz Think of the anime sector with a new sheriff in town, and its name is AniBiz.com. This platform, a brainchild of Nakama, Inc., just landed strategic investments from some heavyweight players in the anime world: TBS Group, Toei Animation, and TV TOKYO Holdings. The Significance of Strategic Support Ain’t no small potatoes here. We're talking the...

Continue Reading
Atrium's ATR 1072 Doses First in Genetic Cardiomyopathy Trial

Updated Category News Views 44

Atrium's Leap in Genetic Cardiomyopathy You know you're living in fascinating times when a company like Atrium Therapeutics rolls the dice on RNA therapeutics, aiming to tackle heart diseases at the genetic level. And that's precisely what they did! They just dosed the first patient in the Phase 1/2 Corventis trial with their drug ATR 1072, setting sail on uncharted...

Continue Reading
Grupo Elektra's Earnings: Revenue Down, EBITDA Up

Updated Category News Views 5

Grupo Elektra's Third Quarter Snapshot Ever look at a company's quarterly earnings and feel like you're in a game of numbers bingo? Here's Grupo Elektra's latest—revenue down but EBITDA up. That's the headline from Latin America's retail and financial services giant, announcing a healthy Ps.53,297 million in revenue for Q3 2026, slightly dipping compared to last year's...

Continue Reading
Envision Energy's AI System Targets Green Mining Future

Updated Category News Views 48

The New Frontier: Mining's Green Shift Mining's bustling heart might just get an eco-friendly tune-up. That's the buzz Envision Energy stoked at All Energy Australia with their new AI-powered energy system aimed squarely at the mining and smelting industry. With wind, solar, battery storage, and all kinds of renewable gimmicks, they're striving to make those hulking...

Continue Reading
Chemours Faces Class Action over Misleading Guidance

Updated Category News Views 46

Legal Storm Brewing for Chemours Investors Seems like The Chemours Company, trading under NYSE:CC, is in some legal hot water right now. With the calendar quickly flipping towards December 7, investors are fronted with a crucial choice: step up to stake their claim as lead plaintiff in a securities fraud class action lawsuit, or watch from the sidelines. The Allegations...

Continue Reading
Oracle Targets US Government With Multicloud AI Plans

Updated Category News Views 24

Oracle's Ambitious Expansion Into Government Cloud Services Oracle, the tech giant that's seen it all, is charging into the US government and public sector's turf with a bold move to get FedRAMP Class D certification for their AI Database services across major cloud providers. Anyone watching Oracle (NYSE: ORCL) over the years knows they don't make these moves lightly....

Continue Reading
Penske Merger Probe: Are Shareholders Getting Shorted?

Updated Category News Views 24

What's Behind the Penske Merger Scrutiny? Out of the blue, we're staring at a massive merger deal, and whispers abound about its legitimacy. Roger Penske and Mitsui & Co., Ltd. are set to acquire Penske Automotive Group, Inc. for $212.00 a share—and some folks ain't happy. BFA Law, a big shot in the securities law scene, is sinking its teeth into this one, digging into...

Continue Reading
Ellucian's Cloud Hat-Trick: Leading AI in Education

Updated Category News Views 66

Turning the Dial on Cloud Innovation What’s gripping the talk of the town? It's the powerhouse, Ellucian, clinching the 2026 Stratus Award for Cloud Computing in the Education category, marking a third straight victory. It’s a trifecta that signals something big in the world of higher ed tech. But what does it mean for investors and the sector at large? Unpacking the...

Continue Reading
Navigating Market Uncertainty with Financial Planning

Updated Category News Views 14

Staying Calm Amid Market Chaos The market's like a roller coaster more often than not, and when headlines scream panic, even the most seasoned of us can begin to doubt our strategies. Jennifer Prosise from The Voyager Group, Ltd., in Joliet, IL, calls out this high-stakes game in HelloNation, emphasizing how financial planning serves as our anchor in the stormy seas of...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 39

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring SEON's Innovations at the Singapore FinTech Festival

Updated Category News Views 244

SEON's Innovative Showcase at the Singapore FinTech Festival At the 10th annual Singapore FinTech Festival, SEON is set to impress attendees with its cutting-edge, AI-powered solutions aimed at fraud prevention and compliance. Taking place from November 12-14, 2025, this significant event presents a perfect platform for SEON to demonstrate how its advanced technologies...

Continue Reading
Saudi Arabian Stock Market Shows Strong Growth in Latest Session

Updated Category News Views 526

Positive Momentum in Saudi Arabia's Stock Market Recently, Saudi Arabian stocks experienced an encouraging close, showcasing a robust increase that reflects a vibrant trading atmosphere within the market. Notable gains were driven primarily by sectors such as Energy & Utilities, Real Estate Development, and Industrial Investment. Tadawul All Share Hits New Heights The...

Continue Reading
Understanding Market Sentiment for W.W. Grainger Inc

Updated Category News Views 114

Understanding Market Sentiment for W.W. Grainger Inc W.W. Grainger Inc's (NYSE: GWW) recent rise in short interest has been notable, with figures showing a 13.94% increase since the last report. Currently, a striking 1.25 million shares are sold short, comprising 3.27% of the total shares available for trading. This increase translates to an average coverage time of...

Continue Reading
F&G Annuities & Life Reports Strong Financial Performance

Updated Category News Views 57

F&G Annuities & Life Achieves Remarkable Sales and Growth F&G Annuities & Life, Inc. (NYSE: FG), a prominent provider of insurance solutions, recently shared its impressive financial results for the third quarter ending September 30, 2024. The company has shown remarkable resilience and growth, reinforcing its position in the annuity and life insurance markets. Financial...

Continue Reading
Capital City Bank Plans to Share First Quarter Earnings Soon

Updated Category News Views 130

Capital City Bank Group, Inc. to Release Earnings Results Capital City Bank Group, Inc. (NASDAQ: CCBG) has exciting news for its investors and stakeholders. This established financial institution, known for its comprehensive banking services, will unveil its first quarter 2025 earnings results on an upcoming Monday, before the markets open. This eagerly anticipated...

Continue Reading